Comparison between Consolidated Construction IPO and Saamya Biotech IPO.
Consolidated Construction IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Saamya Biotech IPO is a Mainboard Fixed Price proposed to list at BSE.
The total issue size of Consolidated Construction IPO is up to ₹188.70 Cr whereas the issue size of the Saamya Biotech IPO is up to ₹15.01 Cr. The final issue price of Consolidated Construction IPO is ₹510.00 per share and of Saamya Biotech IPO is ₹10.00 per share.
| Consolidated Construction IPO | Saamya Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹460.00 per share | |
| Issue Price (Upper) | ₹510.00 per share | |
| Issue Price (Final) | ₹510.00 per share | ₹10.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 12 shares | 500 shares |
| Fresh Issue Size | 37,00,000 shares | 1,50,12,500 shares |
| Fresh Issue Size (Amount) | up to ₹188.70 Cr | up to ₹15.01 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 37,00,000 shares | 1,50,12,500 shares |
| Issue Size Total (Amount) | up to ₹188.70 Cr | up to ₹15.01 Cr |
Consolidated Construction IPO opens on Sep 18, 2007, while Saamya Biotech IPO opens on Sep 25, 2007. The closing date of Consolidated Construction IPO and Saamya Biotech IPO is Sep 21, 2007, and Sep 28, 2007, respectively.
| Consolidated Construction IPO | Saamya Biotech IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 18, 2007 | Sep 25, 2007 |
| Issue Close | Sep 21, 2007 | Sep 28, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 15, 2007 | Oct 19, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Consolidated Construction IPO P/E ratio is , as compared to Saamya Biotech IPO P/E ratio of .
| Consolidated Construction IPO | Saamya Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 82.31 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 74.07 | 35.01 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹1884.73 Cr. | ₹23.08 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 25.6 |
In the Consolidated Construction IPO Retail Individual Investors (RII) are offered 11,10,000 shares while in Saamya Biotech IPO retail investors are offered 11,10,000 shares. Qualified Institutional Buyers (QIB) are offered 22,20,000 shares in Consolidated Construction IPO and 15,00,000 shares in Saamya Biotech IPO.
| Consolidated Construction IPO | Saamya Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 22,20,000 shares | 15,00,000 shares |
| NII | 3,70,000 shares | 67,50,000 shares |
| RII | 11,10,000 shares | 67,50,000 shares |
| Employee | ||
| Others | ||
| Total | 37,00,000 shares | 1,50,00,000 shares |
Consolidated Construction IPO subscribed 81.18x in total, whereas Saamya Biotech IPO subscribed 16.61x.
| Consolidated Construction IPO | Saamya Biotech IPO | |
|---|---|---|
| QIB (times) | 117.68x | 10.99x |
| NII (times) | 67.62x | 7.36x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 12.69x | 27.12x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 81.18x | 16.61x |
